homocysteine has been researched along with Brain Emboli in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azarpazhooh, MR; Bogiatzi, C; Mattia, A; Munoz, C; Quantz, MA; Spence, JD | 1 |
| Funami, Y; Goto, A; Terui, K; Watanabe, K; Yasumura, S; Yokokawa, H | 1 |
2 other study(ies) available for homocysteine and Brain Emboli
| Article | Year |
|---|---|
Association of homocysteine and smoking with cerebral microemboli in patients with mechanical heart valves: a transcranial Doppler study.
Topics: Aged; Biomarkers; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Homocysteine; Humans; Hyperhomocysteinemia; Intracranial Embolism; Male; Middle Aged; Predictive Value of Tests; Registries; Risk Assessment; Risk Factors; Smoking; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Up-Regulation | 2017 |
Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain Infarction; C-Reactive Protein; Cerebral Infarction; Cholesterol, HDL; Comorbidity; Cross-Sectional Studies; Female; Homocysteine; Humans; Intracranial Arteriosclerosis; Intracranial Embolism; Japan; Lipoprotein(a); Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Prevalence; Prognosis | 2008 |